Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prenatal Precision Medicine (NSIGHT2): A Randomized, Blinded, Prospective Study of the Clinical Utility of Rapid Genomic Sequencing for Infants in the Acute-care Setting

NCT03211039 is registered in ClinicalTrials.gov with Rady Pediatric Genomics & Systems Medicine Institute as lead sponsor.

NCT NCT03211039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03211039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prenatal Precision Medicine (NSIGHT2): A Randomized, Blinded, Prospective Study of the Clinical Utility of Rapid Genomic Sequencing for Infants in the Acute-care Setting
Lead sponsor
Rady Pediatric Genomics & Systems Medicine Institute
Phase
Not applicable
Overall status
Unknown status
Start date
June 29, 2017
Completion date
July 30, 2024
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic diseases, genetic syndrome, mendelian disorders